Literature DB >> 28697240

Does Obstructive Sleep Apnea Treatment Reduce Cardiovascular Risk?: It Is Far Too Soon to Say.

Daniel J Gottlieb1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28697240     DOI： 10.1001/jama.2017.7966

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Association of Positive Airway Pressure Prescription With Mortality in Patients With Obesity and Severe Obstructive Sleep Apnea: The Sleep Heart Health Study.

Authors:  Quentin Lisan; Thomas Van Sloten; Pedro Marques Vidal; Jose Haba Rubio; Raphael Heinzer; Jean Philippe Empana
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-06-01       Impact factor: 6.223

2.  Randomized clinical trials of cardiovascular disease in obstructive sleep apnea: understanding and overcoming bias.

Authors:  Allan I Pack; Ulysses J Magalang; Bhajan Singh; Samuel T Kuna; Brendan T Keenan; Greg Maislin
Journal:  Sleep       Date:  2021-02-12       Impact factor: 5.849

3.  Electronic health record-derived outcomes in obstructive sleep apnea managed with positive airway pressure tracking systems.

Authors:  Brian W Locke; Sarah E Neill; Heather E Howe; Michael C Crotty; Jaewhan Kim; Krishna M Sundar
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

4.  PAP and Cardiovascular Events in Adults With Sleep Apnea: Is PAP Useful?

Authors:  Meghna P Mansukhani; Virend K Somers; Shirin Shafazand
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

5.  Optimal Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Reduces Daytime Resting Heart Rate in Prediabetes: A Randomized Controlled Study.

Authors:  Sushmita Pamidi; Florian Chapotot; Kristen Wroblewski; Harry Whitmore; Tamar Polonsky; Esra Tasali
Journal:  J Am Heart Assoc       Date:  2020-10-01       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.